Design Therapeutics (DSGN) Interest Income - Total (2024 - 2026)

Design Therapeutics (DSGN) has 3 years of Interest Income - Total data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Income - Total fell 23.42% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (down 25.9% YoY), and the FY2025 full-year result was $9.7 million, down 24.38% from the prior year.
• Interest Income - Total eased to $2.1 million in Q1 2026, from $2.2 million in the prior quarter.
• In the past five years, Interest Income - Total ranged from a high of $3.3 million in Q1 2024 to a low of $2.1 million in Q1 2026.
• A 3-year average of $2.7 million and a median of $2.7 million in 2025 frame the typical range for Interest Income - Total.
• Peak annual rise in Interest Income - Total reached 17.97% in 2025, while the deepest fall reached 28.62% in 2025.
• Tracing DSGN's Interest Income - Total over 3 years: stood at $3.0 million in 2024, then declined by 28.62% to $2.2 million in 2025, then decreased by 4.7% to $2.1 million in 2026.
• Business Quant data shows DSGN's Interest Income - Total at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $2.3 million in Q3 2025.